Literature DB >> 10998816

Approach to the patient in respiratory distress.

L W Tseng1, L S Waddell.   

Abstract

Respiratory distress is a very common presenting complaint in emergency practice. It is essential that the clinician rapidly determine the underlying cause of the clinical signs using physical examination findings and nonstressful diagnostic tests. Oxygen therapy will often stabilize a patient, allowing for a more complete physical examination and diagnostics, including thoracocentesis, thoracic radiographs, and blood collection for laboratory analysis. The disease processes that cause respiratory distress can be grouped according to anatomic location: the airways, pulmonary parenchyma, pleural space, or thoracic wall. The choice of diagnostic and therapeutic techniques will be dependent on the suspected anatomic origin of disease. Techniques useful in diagnosing airway disorders include oral examination, cervical and thoracic radiographs, fluoroscopy, and bronchoscopy. Therapeutic techniques include intubation and tracheostomy. For parenchymal disease, thoracic radiographs, echocardiography, ultrasound of the thorax, and transtracheal or endotracheal wash can be useful. When the disease process is in the pleural space, thoracocentesis can be both diagnostic and therapeutic. Chest tube placement may be necessary for continuous removal of air or fluid from the pleural space. Monitoring of the respiratory patient can involve serial physical examination, pulse oximetry, and arterial blood gas analysis. It is essential to minimize stress on patients with respiratory distress because decompensation can occur easily, leading to respiratory arrest.

Entities:  

Mesh:

Year:  2000        PMID: 10998816     DOI: 10.1053/svms.2000.6805

Source DB:  PubMed          Journal:  Clin Tech Small Anim Pract        ISSN: 1096-2867


  1 in total

1.  Aetiology and outcome in 90 cats presenting with dyspnoea in a referral population.

Authors:  S Swift; J Dukes-McEwan; S Fonfara; J F Loureiro; R Burrow
Journal:  J Small Anim Pract       Date:  2009-09       Impact factor: 1.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.